IGC Pharma (IGC) Change in Inventory (2010 - 2025)

IGC Pharma (IGC) has reported Change in Inventory for 16 consecutive years, with $67000.0 the latest figure, recorded in Q3 2025.

• On a quarterly basis, Change in Inventory changed N/A year-over-year to $67000.0 in Q3 2025; TTM through Sep 2025 was -$167000.0, a 83.68% increase from a year earlier, with the FY2025 full-year figure at -$180000.0, up 82.14% from the prior year.
• Change in Inventory was $67000.0 for Q3 2025 at IGC Pharma, up from -$84000.0 in the prior quarter.
• Over five years, Change in Inventory peaked at $322000.0 in Q1 2021 and troughed at -$1.9 million in Q1 2022.
• A 5-year average of -$206111.1 and a median of -$7500.0 in 2023 frame the typical range for Change in Inventory.
• The widest YoY moves for Change in Inventory: up 3800.0% in 2022, down 683.54% in 2022.
• Over 5 years, Change in Inventory stood at -$71000.0 in 2021, then soared by 97.18% to -$2000.0 in 2022, then surged by 1250.0% to $23000.0 in 2023, then slumped by 434.78% to -$77000.0 in 2024, then jumped by 187.01% to $67000.0 in 2025.
• The last three Change in Inventory figures came in at $67000.0 (Q3 2025), -$84000.0 (Q2 2025), and -$73000.0 (Q1 2025), per Business Quant data.